Carboplatin 150mg

Carboplatin 150mg

Product Overview

Generic NameCarboplatin 150mg
Brand Name(s)Paraplatin
CategoryAntineoplastic / Cancer
FormVial, injectable solution
Strength150 mg
Therapeutic ClassPlatinum-based antineoplastic alkylating agent
ATC CodeL01XA02

Manufacturing & Regulatory

ManufacturerGenerics,
GMP ComplianceWHO-GMP
DMF/CEPType II/III DMFs
COFEPRIS010.000.4431.00
Free Sale CertificateYes, available as COPP/CPP

Logistics & Export

MOQ10 units
Shelf Life36 months
Storage2–8 °C
IncotermsEx-Works Mexico
Lead Time7 to 10 Days

Documentation Available Upon Request

Certificate of Analysis (PDF)Yes
SDS-Safety Data Sheet (PDF)Upon Request, not publicly posted
CTD Summary (PDF)Not publicly available as parallel traded molecule

Special Notes

Carboplatin is a platinum-based antineoplastic agent used in the treatment of various solid tumours. It acts by forming DNA crosslinks, thereby inhibiting DNA replication and tumour cell proliferation. Carboplatin is commonly used in ovarian cancer, lung cancer, head and neck cancers, testicular cancer, bladder cancer, and other malignancies where platinum-based chemotherapy is clinically indicated